Answer
Women of childbearing potential must have a negative pregnancy test before starting ambrisentan and practise reliable contraception, with monthly pregnancy tests recommended during treatment.
Sources for this answer
- Volibris 5 mg film coated tabletsGlaxoSmithKline UK · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 28Document updated
Sources checked